A Clinical Follow-up Study of Heart Failure Patients.
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Heart Failure
- Sponsor
- Shanghai Zhongshan Hospital
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- NYHA functional class
- Last Updated
- 7 years ago
Overview
Brief Summary
Heart failure (HF), a current worldwide pandemic with an unacceptable high level of morbidity and mortality, brings an enormous medical and societal burden. Chronic HF is characterized by progressive alteration of cardiac structure and function. But the molecular mechanism of these alterations is still not well-established and needs to be discussed further. HF is a highly heterogeneous disease that can be caused by a multiple of diseases. Dilated cardiomyopathy (DCM) and ischemic cardiomyopathy (ICM) are the main causes of this syndrome. Although HF is the common manifestation of DCM and ICM, the etiology and pathogenesis are different. Understanding the different pathophysiological mechanisms will contribute to the prevention and individualized therapy of heart failure. Therefore, this study aims to observation the different characteristics of the molecular biology and clinical courses in DCM and ICM patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •LVEF≤ 55%
- •enlarged left ventricular end-diastolic dimension
- •ICM group: with history of MI or revascularization; ≥ 75% stenosis of LM or proximal LAD; ≥ 75% stenosis of two or more epicardial vessels.
- •symptomatic heart failure
Exclusion Criteria
- •Known malignant tumour diseases
- •Pregnancy or lactation period;
- •Investigators think not suitable to participate in this trial.
Outcomes
Primary Outcomes
NYHA functional class
Time Frame: one year after enrolled
NYHA cardiac functional class
All-cause mortality
Time Frame: one year after enrolled
All-cause mortality during follow-up
Secondary Outcomes
- left ventricular end-diastolic dimension(LVEDD) dilates.(one year after enrolled)
- left ventricular ejection fraction reduces(one year after enrolled)
- hospitalization for cardiac causes(one year after enrolled)